Regencell Historical Income Statement

RGC Stock  USD 3.47  0.02  0.58%   
Historical analysis of Regencell Bioscience income statement accounts such as Other Operating Expenses of 5.4 M, Cost Of Revenue of 840.9 K, Total Operating Expenses of 5.4 M or Total Other Income Expense Net of 255.2 K can show how well Regencell Bioscience Holdings performed in making a profits. Evaluating Regencell Bioscience income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Regencell Bioscience's future profits or losses.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Regencell Bioscience latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Regencell Bioscience is a good buy for the upcoming year.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regencell Bioscience Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

About Regencell Income Statement Analysis

Regencell Bioscience Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Regencell Bioscience shareholders. The income statement also shows Regencell investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Regencell Bioscience Income Statement Chart

Regencell Bioscience Holdings Income Statement is one of the three primary financial statements used for reporting Regencell's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Regencell Bioscience revenue and expense. Regencell Bioscience Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Regencell Bioscience's Selling And Marketing Expenses is projected to increase significantly based on the last few years of reporting. The current year's Reconciled Depreciation is expected to grow to about 929.4 K, whereas Depreciation And Amortization is forecasted to decline to about 658.1 K.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Regencell Bioscience. It is also known as Regencell Bioscience overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Cost Of Revenue

Cost of Revenue is found on Regencell Bioscience income statement and represents the costs associated with goods and services Regencell Bioscience provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.
Most accounts from Regencell Bioscience's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Regencell Bioscience current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regencell Bioscience Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
At present, Regencell Bioscience's Selling And Marketing Expenses is projected to increase significantly based on the last few years of reporting. The current year's Reconciled Depreciation is expected to grow to about 929.4 K, whereas Depreciation And Amortization is forecasted to decline to about 658.1 K.
 2021 2022 2023 2024 (projected)
Total Operating Expenses7.6M6.3M5.6M5.4M
Cost Of Revenue604.4K769.7K885.1K840.9K

Regencell Bioscience income statement Correlations

0.060.60.961.00.960.880.960.530.910.9-0.840.90.9-0.60.66-0.63
0.06-0.050.150.110.210.330.21-0.080.430.22-0.130.20.24-0.150.17-0.16
0.6-0.050.380.60.620.640.641.00.650.67-0.340.680.64-0.330.37-0.35
0.960.150.380.970.940.850.930.30.870.86-0.880.860.86-0.60.66-0.63
1.00.110.60.970.980.910.980.530.930.92-0.860.920.91-0.610.67-0.64
0.960.210.620.940.980.960.990.550.950.97-0.820.970.95-0.610.68-0.65
0.880.330.640.850.910.960.970.580.940.99-0.640.990.99-0.570.63-0.6
0.960.210.640.930.980.990.970.580.960.98-0.760.980.98-0.60.67-0.63
0.53-0.081.00.30.530.550.580.580.590.61-0.280.630.58-0.290.32-0.31
0.910.430.650.870.930.950.940.960.590.92-0.770.920.92-0.590.65-0.62
0.90.220.670.860.920.970.990.980.610.92-0.641.01.0-0.570.63-0.6
-0.84-0.13-0.34-0.88-0.86-0.82-0.64-0.76-0.28-0.77-0.64-0.66-0.610.55-0.60.57
0.90.20.680.860.920.970.990.980.630.921.0-0.660.99-0.570.64-0.61
0.90.240.640.860.910.950.990.980.580.921.0-0.610.99-0.560.62-0.59
-0.6-0.15-0.33-0.6-0.61-0.61-0.57-0.6-0.29-0.59-0.570.55-0.57-0.56-0.70.6
0.660.170.370.660.670.680.630.670.320.650.63-0.60.640.62-0.7-0.98
-0.63-0.16-0.35-0.63-0.64-0.65-0.6-0.63-0.31-0.62-0.60.57-0.61-0.590.6-0.98
Click cells to compare fundamentals

Regencell Bioscience Account Relationship Matchups

Regencell Bioscience income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization9.5K26.5K604.4K769.7K692.7K658.1K
Selling General Administrative311.9K941.5K5.1M4.4M4.0M3.8M
Other Operating Expenses812.4K1.4M7.6M6.3M5.6M5.4M
Operating Income(812.4K)(1.4M)(7.6M)(6.3M)(5.6M)(5.4M)
Ebit(812.4K)(1.4M)(7.6M)(6.3M)(5.6M)(5.4M)
Ebitda(802.9K)(1.4M)(7.0M)(5.5M)(5.0M)(4.7M)
Total Operating Expenses812.4K1.4M7.6M6.3M5.6M5.4M
Income Before Tax(812.4K)(1.3M)(7.6M)(6.1M)(5.5M)(5.2M)
Net Income(812.4K)(1.3M)(7.4M)(5.9M)(5.3M)(5.0M)
Income Tax Expense(1.0)(34.6K)(171.8K)(191.2K)(172.1K)(163.5K)
Selling And Marketing Expenses114.2K1.6K25.3K262.7K302.1K317.2K
Net Income From Continuing Ops(812.4K)(1.3M)(7.6M)(6.1M)(5.5M)(5.2M)
Research Development386.2K438.3K2.5M1.6M1.8M1.1M
Reconciled Depreciation9.5K26.5K604.4K769.7K885.1K929.4K
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Regencell Bioscience in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Regencell Bioscience's short interest history, or implied volatility extrapolated from Regencell Bioscience options trading.

Currently Active Assets on Macroaxis

When determining whether Regencell Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Regencell Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Regencell Bioscience Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Regencell Bioscience Holdings Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regencell Bioscience Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the Regencell Bioscience information on this page should be used as a complementary analysis to other Regencell Bioscience's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Regencell Stock analysis

When running Regencell Bioscience's price analysis, check to measure Regencell Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regencell Bioscience is operating at the current time. Most of Regencell Bioscience's value examination focuses on studying past and present price action to predict the probability of Regencell Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regencell Bioscience's price. Additionally, you may evaluate how the addition of Regencell Bioscience to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Bonds Directory
Find actively traded corporate debentures issued by US companies
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Is Regencell Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regencell Bioscience. If investors know Regencell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regencell Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.45)
Return On Assets
(0.26)
Return On Equity
(0.42)
The market value of Regencell Bioscience is measured differently than its book value, which is the value of Regencell that is recorded on the company's balance sheet. Investors also form their own opinion of Regencell Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Regencell Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regencell Bioscience's market value can be influenced by many factors that don't directly affect Regencell Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regencell Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Regencell Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regencell Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.